Tackling performance requirements in the more prescriptive world of IVDR, How tighter rules modernize and safeguard Indias medical devices market, PharmaLexexpands Australia footprint through merger plan with pharmacovigilance leader Cpharm, IPI speaks with experts at PharmaLex on Integrated Product Development, Transaction further advances leadership in specialty, with key commercial enablement solutions to support biopharmaceutical partners. Management believes that this non-GAAP financial measure is useful to investors because it eliminates the per share impact of items that are outside the control of the Company or that we consider to not be indicative of our ongoing operating performance due to their inherent unusual, non-operating, unpredictable, non-recurring, or non-cash nature. approximately 14,000 people. The $190.00 per [27], In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The access code for the replay is 10151119. products, of which over 25,000 are stocked in our distribution centers, sourced receive new, life-saving treatments as soon as possible. time. [32][33] AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. file a Solicitation/Recommendation Statement on Schedule 14D-9 relating to the May 1, 2023 12:39 UTC. Therefore, the Company believes that the presentation of this non-GAAP financial measure provides useful supplementary information to, and facilitates additional analysis by, investors. As the largest facility within the ICS network, the new The acquisition of Alliance Healthcare expands our reach and solutions in pharmaceutical distribution and adds to AmerisourceBergens breadth and depth of global manufacturer services. CONSHOHOCKEN, Pa.-- ( BUSINESS WIRE )--AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of its acquisition of the majority of . Under the terms and conditions of the merger agreement, AmerisourceBergenInvestors:Bennett S. Murphy+1 610-727-3693bmurphy@amerisourcebergen.com, Media:Gabe Weissman+1 610-727-3696gweissman@amerisourcebergen.com, Walgreens Boots AllianceInvestors:Gerald Gradwell and Jay Spitzer+1 847-315-2922, Media:Media RelationsUSA / Aaron Radelet and Morry Smulevitz +1-847-315-0517International +44-(0)20-7980-8585, Company deploying proceeds of $6.5 billion to pay down debt and boost strategic healthcare investments Extended and expanded commercial agreements to drive incremental growth and synergies. The suit was filed along with lawsuits against Cardinal Health and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets. there is a heightened demand for rigorous and customized storage solutions. distribution and services businesses. markets, we will collaboratively launch the next generation of superior animal The transaction, which is expected to close by AmerisourceBergens fiscal year-end 2021, is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals. Upon closing, the acquisition of Alliance Healthcare is expected to deliver high-teens percentage accretion to AmerisourceBergen's adjusted diluted EPS in the first fiscal year. The Company undertakes no obligation to publicly update or revise any forward-looking statements, except as required by the federal securities laws. ET. AmerisourceBergen to acquire MWI Veterinary Supply (MWI), the leading animal [3] In 2012, the firm was the largest by revenue based in Pennsylvania. We are excited to complete the acquisition and extend a warm welcome to the talented team at Alliance Healthcare, said Steven H. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen. [34][35] States countered with $45 billion.[36]. demands of todays customers and patients. Executive Officer. customers unique set of requirements. AmerisourceBergen has updated its fiscal year 2021 financial guidance to reflect the expected contribution from the closing of the Alliance Healthcare acquisition and the weighted average share count impact of the 2 million shares of AmerisourceBergen common stock that the Company delivered at closing of the transaction. A replay of the webcast will be posted on investor.amerisourcebergen.com approximately two hours after the completion of the call and will remain available for 30 days. No access code is required. capabilities, and better position the company to continue meeting each Adjusted free cash flow: For fiscal year 2021, AmerisourceBergen has defined the non-GAAP financial measure of adjusted free cash flow as net cash provided by operating activities, excluding other significant unpredictable or non-recurring cash payments or receipts relating to legal settlements, minus capital expenditures. period ended January 9, 2015, the last trading day prior to the announcement. Ohio-based distribution center will enable ICS to meet the markets growing This is the 27th consecutive year that WBA or its predecessor company, Walgreen Co., has been named to the list. healthier futures. Xcenda will become part of AmerisourceBergen Specialty . In addition, AmerisourceBergen will be presenting at the J.P. Morgan Conshohocken, Pennsylvania The Company now expects: The Company continues to have strong performance across its businesses and expects to update the rest of its previously announced fiscal 2021 financial guidance when it reports results for the third quarter of fiscal 2021. Any statements that are not historical fact (including statements PharmaLexs results will be reported as a component within AmerisourceBergens International Healthcare Solutions segment. This acquisition is expected to have no impact on AmerisourceBergens dividend policy. Learn more at investor.amerisourcebergen.com. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. The new facility, which will serve Walgreens Boots Alliance will be able to increase its focus on expanding its core retail pharmacy businesses, bringing even greater healthcare offerings to patients and customers and further accelerating its progress on its clear set of strategic priorities. This deal will enable significant value creation for both companies and will generate new synergies in addition to those already captured. needs for specialty services, such as time-sensitive and ultra-frozen TPG has agreed to acquire a majority interest in OneOncology, and AmerisourceBergen will acquire a minority interest in the company. of managed warehouse across four strategic locations within the United States. We offer expanded, integrated logistics solutions designed to support pharmaceutical manufacturers and cell and gene therapy innovators regardless of size of the operation or where you are in the commercialization journey. For more information, go to www.amerisourcebergen.com. AmerisourceBergen: The biggest Pennsylvania company you never heard of, by David Sell, Philadelphia Inquirer, July 15, 2012, Learn how and when to remove these template messages, Learn how and when to remove this template message, U.S. Department of Health and Human Services (HHS), United States Securities and Exchange Commission, "AmerisourceBergen, Form 8-K, Current Report, Filing Date Aug 30, 2001", "AmerisourceBergen Announces Intent to Change Name to Cencora", "AmerisourceBergen Added to S&P 500 index", "UPDATE 2-Amerisource CEO Yost to retire, Collis to succeed", "AmerisourceBergen Acquires World Courier", "Walgreens Boots buys bigger stake in AmerisourceBergen", "AmerisourceBergen to acquire World Courier Group", "AmerisourceBergen to buy PharMEDium for $2.58 billion", "AmerisourceBergen Completes Acquisition of HD Smith", "Former H.D. With the addition of World Courier,[9] the largest specialty courier company in the world, over 150 company-owned offices around the globe were added to the company. We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them. unanimously approved the transaction. [18][19], For the fiscal year 2019, AmerisourceBergen reported earnings of US$1.11 billion, with an annual revenue of US$179.58 billion. The tender offer for the outstanding common stock of MWI has not yet commenced. today the grand opening of its newest third-party logistics (3PL) Supplemental Information Regarding Non-GAAP Financial Measures third full year, driven primarily by the benefits of AmerisourceBergens scale 610-727-3693 Federal prosecutors say the drug wholesaler AmerisourceBergen Corp. failed to report suspicious orders for . increase supply chain efficiency, maximize return on investments and enhance pharmaceutical supply chain. and a part of AmerisourceBergen, announced More than a third-party logistics provider, ICS is your strategic partner. Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail and wholesale pharmacy, touching millions of lives every day through dispensing and distributing medicines, its convenient retail locations, digital platforms and health and beauty products. The non-GAAP financial measure is presented because management uses non-GAAP financial measures to evaluate the Companys operating performance, to perform financial planning, and to determine incentive compensation. enhance patient care. MWIs stockholders are strongly advised to read MWI is the premier supply chain company in animal health, with leading Words such as "expect," "likely," "outlook," "forecast," "would," "could," "should," "can," "project," "intend," "plan," "continue," "sustain," "synergy," "on track," "believe," "seek," "estimate," "anticipate," "may," "possible," "assume," variations of such words, and similar expressions are intended to identify such forward-looking statements. MWI operates and in AmerisourceBergen's future operating results relating to These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented in the press release. AmerisourceBergen will serve as Civica, Inc.s exclusive distribution partner and provide supply chain support for Civicas products and a best-in-class customer experience. In March 2016 Walgreens Boots Alliance Inc. announced it would exercise an option to purchase 22.7 million shares of AmerisourceBergen stock and thereby control 15% of the company.[10]. www.amerisourcebergen.com. AmerisourceBergen management believes that this non-GAAP financial measure is useful to investors because it eliminates the impact of items that are unusual, unpredictable, and non-recurring in nature. [29] Had the states gone to court, the companies could have faced up to $95 billion in penalties. and nutritional products. Note: FY22 GAAP Operating Income of $2,366M. Within AmerisourceBergen, ASD Healthcare is the nation's largest specialty pharmaceutical distributor for oncology and supportive care products to health systems. About AmerisourceBergen We market these products to our customers in both the . The Alliance Healthcare transaction and expanded strategic agreement are expected to: Under the terms of the purchase agreement, which has been approved by the AmerisourceBergen and Walgreens Boots Alliance Boards of Directors, AmerisourceBergen will pay WBA $6.275 billion in cash, subject to a customary working capital and net-debt adjustment, and deliver 2 million shares of AmerisourceBergen common stock at closing of the transaction. Having the ability to invest in sustainable environmental and social wellbeing is an important part of our attitude to business as well as helping to reinforce our values. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances and speak only as of the date hereof. AmerisourceBergen intends to acquire any shares of MWI not tendered into the Factors that could cause or contribute to such differences include, but are not limited to: the parties ability to meet expectations regarding the timing of the proposed acquisition and related strategic transactions; the parties ability to consummate the proposed acquisition and related strategic transactions; the conditions to the completion of the proposed acquisition and related strategic transactions; the regulatory approvals required for the proposed acquisition and related strategic transactions not being obtained on the terms expected or on the anticipated schedule or at all; inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements and the providing of estimates of financial measures, in accordance with GAAP and related standards, or on an adjusted basis; the integration of Alliance Healthcare into AmerisourceBergen being more difficult, time consuming or costly than expected; AmerisourceBergens or Alliance Healthcares failure to achieve expected or targeted future financial and operating performance and results; the possibility that the combined company may be unable to achieve expected benefits, synergies and operating efficiencies in connection with the proposed acquisition and related strategic transactions within the expected time frames or at all; customer loss and business disruption being greater than expected following the proposed acquisition and related strategic transactions; the retention of key employees being more difficult following the proposed acquisition and related strategic transactions; the effect of any changes in customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of the business of AmerisourceBergen or Alliance Healthcare; and uncertainties and matters beyond the control of management and other factors described under Risk Factors in each of AmerisourceBergens and WBAs Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other filings with the SEC. Except as required by applicable law, AmerisourceBergen, Alliance Healthcare and WBA undertake no obligation to update any statements herein for revisions or changes after the date of this communication. Read their testimonials. weighted average closing price of MWIs common stock over the three-month Title Model is a unique distribution solution allowing ICS to take title of the product on behalf of pharmaceutical manufacturers. ICS - AmerisourceBergen. [32], As part of the civil settlement, ABC admitted that between January 2001 and January 2014, MII and OSC operated a program that created, packed and shipped millions of PFS to oncology practices for administration to vulnerable cancer patients (the PFS Program). health products and services together., This transaction represents a terrific opportunity for MWI and our We align supply chain strategy to your business . Contact: Bennett S. Murphy It has also divested 3 assets. ICS - AmerisourceBergen is a Pharmaceutical Manufacturing, Drug Stores & Pharmacies, and Healthcare Logistics company located in Frisco, Texas with $47.00 Million in revenue and 397 employees. events or otherwise, except as required by law. The deal adds a network of cancer specialists to the company's portfolio and builds up its practice . AmerisourceBergen is a pharmaceutical sourcing and distribution services company, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and care. They also distribute a line of brand name and generic pharmaceuticals, over-the-counter (OTC) health care products and home health care supplies . tendering at least a majority of outstanding shares in the tender offer, We pair advanced technologies with expert human support to drive faster access to therapy and enhance the patient experience. In addition to distribution and logistics, we help pharmaceutical manufacturers bring their products to market and assist with each step from pre-commercial and clinical trial to broad market availability and patient adherence. These statements are based on current expectations of the management of AmerisourceBergen (the Company) and are subject to uncertainty and changes in circumstances and speak only as of the date hereof. Through our daily workand This is due to the inherent difficulty of forecasting the timing or amount of various items that have not yet occurred, are out of the companys control and/or cannot be reasonably predicted, and that would impact diluted net earnings per share, the most directly comparable forward-looking GAAP financial measure. bmurphy@amerisourcebergen.com, Health Economics, Market Access & Regulatory Consulting, Patient Access, Affordability & Adherence Services, Global Storage, Transport & Outsourced Logistics, Revenue of at least $210 billion, up from revenue growth in the high-single digit percent range; and. The live call will also be webcast via the Companys website at investor.amerisourcebergen.com. J.P. Morgan acted as financial advisor . Then the drug, including the overfill, was extracted and repackaged into syringes. AmerisourceBergen adds FirstView's copay program management and payment processing services to its existing portfolio of patient support and healthcare solutions, creating an enhanced and . health distribution company in the United States. MWI will be presenting at the J.P. Morgan Healthcare Conference in San Todays announcements will expand our reach and solutions in pharmaceutical distribution and add to AmerisourceBergens breadth and depth of global manufacturer services, supporting our ability to create differentiated value for all our stakeholders. products of all sizes, temperatures and storage needs. Animal health is a growing market in the US and internationally, and is a logical extension of our pharmaceutical Supplemental Information Regarding AmerisourceBergens Non-GAAP Financial Measures. Winnebago Industries Completes Acquisition Of Lithionics Battery. AmerisourceBergen, Im confident MWI will continue to lead our industry in Such forward-looking statements may include, without limitation, statements about the proposed acquisition and related strategic transactions, the expected timetable for completing the proposed acquisition and related strategic transactions, the benefits and synergies of the proposed acquisition and related strategic transactions, future opportunities for AmerisourceBergen and WBA and any other statements regarding AmerisourceBergens, Alliance Healthcares or WBAs future operations, financial or operating results, capital allocation, dividend policy, debt ratio, anticipated business levels, future earnings, planned activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. About AmerisourceBergen share consideration represents an approximately 17.4% premium to the volume Certain of the statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Securities Exchange Act). Karl has been with ICS since March of 2003 and was a consultant for our ERP solution for 5 years prior to joining the company. In 2023, we intend to evolve our global brand and corporate identity to become Cencora. Includes $5M of intersegment eliminations. These announcements between the two global enterprises continue to build on the close partnership and strong foundation that began in 2013. The presentation ourselves to change through investments and innovation in order to meet the [7] David Yost was CEO of Amerisource prior to the merger and remained in the position after the companies merged.[8]. The company provides tech-enabled services ranging from clinical development consulting to marketing authorization, enabling clients to efficiently bring products to global markets and diverse patient populations. filings with the Securities and Exchange Commission (the SEC) from time to [32], ABCs scheme enabled it to bill multiple health care providers for the same vial of drug, causing some of those providers to bill the Federal Health Care Programs for the same vial more than once. variety of value-added services, including on-line ordering via our e-commerce AmerisourceBergen is ranked #10 on the Fortune 500 with more than $200 billion in annual revenue. AmerisourceBergens acquisition of Alliance Healthcare will provide even stronger support for pharmacies and pharmacists across the globe and integrated solutions for pharmaceutical manufacturers. Such forward-looking statements include the medication, optimizing supply chain efficiency and enhancing patient care. that MWIs stockholders tender their shares to AmerisourceBergen. the supply chain for pharmaceutical products that require special handling. Our wholesale and specialty distribution services ensure that crucial medications efficiently, reliably and securely reach their destinations every day. Investors: pharmaceutical distribution center in Ohio. These supplemental non-GAAP financial measures are presented because management has evaluated the companys financial results both including and excluding the adjusted items or the effects of foreign currency translation, as applicable, and believes that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the companys business from period to period and trends in the companys historical operating results. The 300,000 sq. animal health market.. [31], In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. 1. A total of 7 acquisitions came from private equity firms. these tender offer materials, as well as any other documents relating to the With the We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. containing the words "believes," "plans," AmerisourceBergen has 26 pharmaceutical distribution centers in the US, nine distribution centers in Canada, four specialty distribution centers in the US, and over 1 million square feet of packaging production capacity in the US and the UK. This transaction provides great benefit for both companies and is a logical step following the continued success of our long-term strategic relationship, said Ornella Barra, Chief Operating Officer, International, Walgreens Boots Alliance, Inc. The Alliance Healthcare teams are joining a global pharmaceutical distribution leader and trusted partner in AmerisourceBergen, and we look forward to continuing to work together as strategic partners. PharmaLexs highly complementary business and strong market reputation will deepen our partnerships with manufacturers, advancing our role as a strategic partner of choice as we support end-to-end clinical and commercial enablement solutions for our pharma customers. The companys businesses have been recognized for their Corporate Social Responsibility. Health Economics, Market Access & Regulatory Consulting, Patient Access, Affordability & Adherence Services, Global Storage, Transport & Outsourced Logistics. AmerisourceBergen Corporation is an American drug wholesale company that was formed by the merger of Bergen Brunswig and AmeriSource in 2001.
